Results 51 to 60 of about 10,808 (171)
Sociodemographic and self-reported clinical history of study participants according to chikungunya virus (CHIKV) immune status during follow-up.
Jessica A. Plante (11649163) +18 more
core +1 more source
Meeting Report: Fourth Correlates of Protection for Next Generation Influenza Vaccines
ABSTRACT Background This report summarizes the discussions and conclusions from the fourth “Correlates of Protection for Next Generation Influenza Vaccines” meeting, which took place in Vienna, Austria, from October 15, 2025, to October 17, 2025. Conclusion Discussions on influenza virus correlates of protection built on prior meetings, with particular
Alina Tscherne +3 more
wiley +1 more source
Abstract With the introduction and adaptation of non‐native mosquitoes to cities, vector‐borne diseases are emerging concerns in the United States of America. A growing body of literature suggests that mosquito infestations and associated diseases are a greater burden in socioeconomically disadvantaged areas within the heterogeneous urban ecosystem ...
Sarah E. Rothman +2 more
wiley +1 more source
Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection. [PDF]
PURPOSE: Chikungunya virus (CHIKV) causes endemic or epidemic outbreaks of CHIKV fever, which is a mosquitoe- transmitted viral disease in Africa, India, South-East Asia, and recently Southern Europe.
Kim, J +5 more
core +1 more source
Unveiling the Molecular Profile and Antiviral Potential of Costus arabicus L. Against Zika Virus
Analysis of the chemical profile and antiviral potential of Costus arabicus L. extracts. ABSTRACT Widely used in Brazilian folk medicine, Costus arabicus L. (Canarana) is a herbaceous plant with promising pharmacological potential. Here, we profile the molecular composition of extracts from different plant organs and evaluate their in vitro activity ...
Alice Rhelly V. Carvalho +9 more
wiley +1 more source
Pathogenicity and virulence of chikungunya virus
Chikungunya virus (CHIKV) is a mosquito-transmitted, RNA virus that causes an often-severe musculoskeletal illness characterized by fever, joint pain, and a range of debilitating symptoms.
Freppel, Wesley +3 more
core +1 more source
Accelerate the Highly Efficient Development of mRNA Vaccines Through Advanced Computational Methods
This review explores the recent advancements in applying computational methods to optimize mRNA vaccines, with a primary focus on improvements in sequence design and delivery systems. ABSTRACT mRNA medicine is an emerging therapeutic approach that utilizes messenger RNA to synthesize functional proteins directly within target cells.
Ruichu Gu +5 more
wiley +1 more source
Increased number of cases of Chikungunya virus (CHIKV) infection imported from the Caribbean and Central America to northern Italy, 2014 [PDF]
SUMMARYThis report describes an increased number of cases of Chikungunya virus (CHIKV) infection imported in northern Italy (Emilia-Romagna region) during the period May–September 2014, indicating that the recent spread of CHIKV and its establishment in the Caribbean and in central America, resulted in a high number of imported cases in Europe, thus ...
G, Rossini +4 more
openaire +2 more sources
This review explores nanoparticle (NP)‐based biosensors and nanovaccine platforms for arboviral infections, highlighting their design, performance, and translational potential. By comparing case studies across viruses, it identifies gold‐standard nanomaterials such as gold NPs (AuNPs), zinc oxide NPs (ZnONPs), molybdenum disulfide (MoS2) nanocomposites,
Peyman Halvaeikhanekahdani +3 more
wiley +1 more source
Chikungunya virus (CHIKV) is considered a public health problem due to its rapid spread and high morbidity. This study aimed to determine the genetic diversity and phylogenetic relationships of CHIKVs in Colombia.
Puerta González, Andrés +7 more
core +1 more source

